DR. GEORGE ANASTASSOV, DDS, MD
RENOWNED ORAL SURGEON, CRANIOFACIAL SURGEON
From the world’s first patented cannabis chewing gum to toothpaste, mouthwash and more everyday personal use consumer products, Dr. George Anastassov, DDS, MD has been at the forefront of consumer product development for eight years. Dr. Anastassov is the co-Founder and CEO of Netherlands-based APIRx. Dr. Anastassov and team have developed a wide range of cannabis products that incorporate CBD, THC and the cannabinoid that creates both – cannabigerol (CBG).
Cannabigerol is “the mother” of all cannabinoids; it is one of more than 120 identified cannabinoid compounds found in the plant genus cannabis. Cannabigerolic acid is the precursor of CBD and tetrahydrocannabinolic acid (THCA) which is the precursor of tetrahydrocannabinol (THC). Essentially, CBG makes CBDA that becomes CBD and THC. CBG is the non-acidic form of cannabigerolic acid and, like CBD, is non-psychotropic. CBG research indicates that it has a calming effect and with other cannabinoid consumption. Additional properties include pain relief, neuroprotection, anti-inflammatory, antibacterial, and more.
With Dr. Anastassov’s experience with craniofacial and oral surgery plus overall oral health, CBG is now on the leading edge of new cannabis personal care product development. Attend Dr. Anastassov’s informative presentation to learn about the properties of CBG and how easy it is to incorporate into one’s daily routine.